JCRファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/11/10 | 1,831 | 1,878 | 1,820 | 1,855 | +7 | +0.4% | 331,500 |
2022/11/09 | 1,870 | 1,887 | 1,844 | 1,848 | -29 | -1.5% | 352,700 |
2022/11/08 | 1,912 | 1,925 | 1,871 | 1,877 | -17 | -0.9% | 424,300 |
2022/11/07 | 1,920 | 1,921 | 1,876 | 1,894 | -34 | -1.8% | 454,100 |
2022/11/04 | 2,006 | 2,011 | 1,924 | 1,928 | -102 | -5% | 579,000 |
2022/11/02 | 2,065 | 2,078 | 2,030 | 2,030 | -67 | -3.2% | 473,700 |
2022/11/01 | 2,230 | 2,239 | 2,095 | 2,097 | -118 | -5.3% | 554,400 |
2022/10/31 | 2,181 | 2,246 | 2,154 | 2,215 | +54 | +2.5% | 646,800 |
2022/10/28 | 2,092 | 2,193 | 2,088 | 2,161 | +36 | +1.7% | 989,600 |
2022/10/27 | 2,190 | 2,226 | 2,093 | 2,125 | +78 | +3.8% | 1,375,900 |
2022/10/26 | 1,984 | 2,065 | 1,979 | 2,047 | +111 | +5.7% | 613,000 |
2022/10/25 | 1,981 | 1,986 | 1,932 | 1,936 | -34 | -1.7% | 390,600 |
2022/10/24 | 2,005 | 2,018 | 1,965 | 1,970 | -13 | -0.7% | 327,900 |
2022/10/21 | 1,990 | 2,015 | 1,972 | 1,983 | -15 | -0.8% | 396,600 |
2022/10/20 | 2,048 | 2,074 | 1,995 | 1,998 | -60 | -2.9% | 430,900 |
2022/10/19 | 2,080 | 2,088 | 2,022 | 2,058 | -17 | -0.8% | 922,900 |
2022/10/18 | 2,099 | 2,106 | 2,051 | 2,075 | +11 | +0.5% | 330,500 |
2022/10/17 | 2,076 | 2,086 | 2,037 | 2,064 | -55 | -2.6% | 338,000 |
2022/10/14 | 2,104 | 2,124 | 2,070 | 2,119 | +51 | +2.5% | 417,400 |
2022/10/13 | 2,121 | 2,134 | 2,068 | 2,068 | -56 | -2.6% | 217,600 |
2022/10/12 | 2,130 | 2,160 | 2,115 | 2,124 | -3 | -0.1% | 232,600 |
2022/10/11 | 2,197 | 2,207 | 2,125 | 2,127 | -120 | -5.3% | 393,300 |
2022/10/07 | 2,231 | 2,263 | 2,223 | 2,247 | -18 | -0.8% | 300,600 |
2022/10/06 | 2,266 | 2,288 | 2,255 | 2,265 | +1 | ±0% | 287,300 |
2022/10/05 | 2,250 | 2,285 | 2,215 | 2,264 | +15 | +0.7% | 430,200 |
2022/10/04 | 2,215 | 2,255 | 2,203 | 2,249 | +83 | +3.8% | 398,600 |
2022/10/03 | 2,160 | 2,172 | 2,115 | 2,166 | +1 | ±0% | 234,000 |
2022/09/30 | 2,198 | 2,224 | 2,156 | 2,165 | -21 | -1% | 292,800 |
2022/09/29 | 2,124 | 2,192 | 2,104 | 2,186 | +101 | +4.8% | 380,800 |
2022/09/28 | 2,058 | 2,098 | 2,033 | 2,085 | +27 | +1.3% | 438,000 |
2022/09/27 | 2,058 | 2,075 | 2,029 | 2,058 | +16 | +0.8% | 257,500 |
2022/09/26 | 2,040 | 2,067 | 2,020 | 2,042 | -22 | -1.1% | 306,900 |
2022/09/22 | 2,049 | 2,081 | 2,047 | 2,064 | -35 | -1.7% | 200,900 |
2022/09/21 | 2,084 | 2,122 | 2,081 | 2,099 | -20 | -0.9% | 159,900 |
2022/09/20 | 2,155 | 2,164 | 2,106 | 2,119 | -29 | -1.4% | 169,200 |
2022/09/16 | 2,131 | 2,156 | 2,122 | 2,148 | +1 | ±0% | 284,000 |
2022/09/15 | 2,169 | 2,177 | 2,135 | 2,147 | -15 | -0.7% | 209,500 |
2022/09/14 | 2,136 | 2,185 | 2,136 | 2,162 | -42 | -1.9% | 249,800 |
2022/09/13 | 2,171 | 2,225 | 2,171 | 2,204 | ±0 | ±0% | 304,900 |
2022/09/12 | 2,206 | 2,210 | 2,164 | 2,204 | +29 | +1.3% | 209,200 |
2022/09/09 | 2,140 | 2,211 | 2,138 | 2,175 | +37 | +1.7% | 357,500 |
2022/09/08 | 2,170 | 2,185 | 2,135 | 2,138 | +51 | +2.4% | 396,800 |
2022/09/07 | 2,081 | 2,095 | 2,049 | 2,087 | +29 | +1.4% | 302,300 |
2022/09/06 | 2,074 | 2,103 | 2,054 | 2,058 | -11 | -0.5% | 233,100 |
2022/09/05 | 2,073 | 2,092 | 2,048 | 2,069 | -26 | -1.2% | 294,600 |
2022/09/02 | 2,154 | 2,158 | 2,086 | 2,095 | -59 | -2.7% | 439,400 |
2022/09/01 | 2,143 | 2,172 | 2,127 | 2,154 | -22 | -1% | 231,100 |
2022/08/31 | 2,137 | 2,176 | 2,130 | 2,176 | +40 | +1.9% | 259,700 |
2022/08/30 | 2,131 | 2,147 | 2,111 | 2,136 | +6 | +0.3% | 354,600 |
2022/08/29 | 2,123 | 2,153 | 2,117 | 2,130 | -70 | -3.2% | 350,600 |
501~
550
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「JCRファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム